Symbol: ABBV Sector: Healthcare Industry: Drug Manufacturers
Update: 2019-06-10 07:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2019-03-31 |
7,828,000,000 |
7,828,000,000 |
1,694,000,000 |
6,134,000,000 |
3,124,000,000 |
3,010,000,000 |
2,456,000,000 |
- |
- |
n.a. |
- |
- |
- |
- |
- |
- |
- |
1,444,000,000 |
Update: 2019-06-10 07:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2018-12-31 |
8,305,000,000 |
8,305,000,000 |
2,022,000,000 |
6,283,000,000 |
8,724,000,000 |
-2,441,000,000 |
-1,826,000,000 |
16,945,000,000 |
59,352,000,000 |
67,798,000,000 |
-8,446,000,000 |
7,289,000,000 |
5,308,000,000 |
8,061,000,000 |
40,310,000,000 |
-716,000,000 |
3,392,000,000 |
6,795,000,000 |
2018-09-30 |
8,236,000,000 |
8,236,000,000 |
1,835,000,000 |
6,401,000,000 |
3,242,000,000 |
3,159,000,000 |
2,747,000,000 |
18,465,000,000 |
66,164,000,000 |
69,085,000,000 |
-2,921,000,000 |
8,015,000,000 |
4,021,000,000 |
8,785,000,000 |
40,508,000,000 |
4,477,000,000 |
4,524,000,000 |
1,323,000,000 |
2018-06-30 |
8,278,000,000 |
8,278,000,000 |
1,934,000,000 |
6,344,000,000 |
3,582,000,000 |
2,762,000,000 |
1,983,000,000 |
13,845,000,000 |
61,641,000,000 |
65,016,000,000 |
-3,375,000,000 |
3,547,000,000 |
6,530,000,000 |
3,743,000,000 |
37,109,000,000 |
-5,425,000,000 |
2,866,000,000 |
1,322,000,000 |
2018-03-31 |
7,934,000,000 |
7,934,000,000 |
1,927,000,000 |
6,007,000,000 |
3,104,000,000 |
2,903,000,000 |
2,783,000,000 |
20,444,000,000 |
69,342,000,000 |
65,789,000,000 |
3,553,000,000 |
9,007,000,000 |
6,381,000,000 |
9,474,000,000 |
37,287,000,000 |
-311,000,000 |
2,645,000,000 |
1,313,000,000 |
Update: 2019-06-10 07:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2017-12-31 |
7,739,000,000 |
7,739,000,000 |
2,279,000,000 |
5,460,000,000 |
3,631,000,000 |
1,829,000,000 |
52,000,000 |
21,223,000,000 |
70,786,000,000 |
65,689,000,000 |
5,097,000,000 |
9,303,000,000 |
6,415,000,000 |
9,789,000,000 |
37,368,000,000 |
857,000,000 |
2,584,000,000 |
1,695,000,000 |